CDNA.NASDAQCaredx, INC

Form 4: CareDx Director Riggsbee Receives RSU Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Director Richard Bryan Riggsbee was granted 9,795 restricted stock units in CareDx, Inc. as part of standard equity compensation.

Summary

  • Director Richard Bryan Riggsbee acquired 9,795 restricted stock units (RSUs) of CareDx, Inc. common stock.
  • The transaction occurred on June 12, 2026.
  • The RSUs were granted at a price of $0 per share.
  • Following this transaction, the director's total beneficial ownership increased to 39,312 shares.
  • The RSUs vest on the earlier of the one-year anniversary of the grant or the day before the first Annual Meeting following the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

  • Alignment of director interests with shareholders through equity-based compensation.
  • Standardized vesting schedule ensures long-term commitment to the company.

Negatives

  • None identified; this is a routine equity grant for a board member.

Risks

  • Vesting is subject to the director's continuous service to the company.

Future Outlook

The RSUs are expected to vest within one year, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices in the biotechnology sector to ensure board alignment with long-term shareholder value.

Comparison to Industry Standards

  • The grant of RSUs to directors is consistent with standard compensation practices for mid-cap biotechnology companies.
  • The vesting period of one year or the next annual meeting is a common industry benchmark for director equity awards.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of AttorneyAuthorization of Jeffrey Adam Novack and Colleen Martin-Garcia to file Section 16 reports on behalf of the director.07/18/2025Standard administrative procedure to ensure timely regulatory compliance.

Stakeholder Impact

  • Shareholders: Minimal impact; reflects standard director compensation structure.

Next Steps

  • Vesting of the 9,795 RSUs on the earlier of the one-year anniversary or the next Annual Meeting.

Key Dates

DateDescription
07/18/2025Date of Power of Attorney execution.
06/12/2026Date of RSU grant transaction.
06/16/2026Date of filing.

Keywords

CareDx, CDNA, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.